The proposed Project will be part of AIIB’s COVID-19 Crisis Recovery Facility (the Facility) and will be co-financed with the World Bank (WB), through the International Development Association (IDA), under the second additional financing of the Cote d’Ivoire Strategic Preparedness and Response Project (CIV-SPRP). The Project will: (i) increase the availability and roll-out of eligible vaccines for coronavirus disease 2019 (COVID-19), to support the Government of Cote d’Ivoire in its target to expand COVID-19 vaccination coverage to 70 percent of the population and provide booster doses to 9.9 million persons (35 percent of the population); (ii) reinforce preparedness and response interventions at scale; and (iii) strengthen relevant health systems to ensure effective vaccine deployment in Cote d’Ivoire, sustained containment of COVID-19, and positioning of the country to detect and respond to future disease outbreaks in a swift, effective and efficient manner.

The Project will comprise 3 components:

Component 1: Emergency COVID-19 Response to finance the purchase and deployment of vaccines and to strengthen related health systems
Component 2: Health communication and community engagement
Component 3: Project implementation, management, and monitoring and evaluation
AIIB will finance all three components.

The WB’s support to the CIV-SPRP consists of an initial IDA credit of USD 35 million (referred to as the Initial WB Financing), focused on initial measures to contain the pandemic, and an Additional WB Financing (AF) IDA credit of USD 100 million (referred to as the First WB AF), focused on vaccine deployment. The WB's total combined financing for this Project and the activities supported under the Initial WB Financing and the First WB AF is USD 215 million.

Activities, under all three components, have been underway since Apr. 2021, within the framework of the CIV-SPRP. The proposed project will scale up activities under all three components and extend the closing date of the project from Jun. 30, 2022 to June 30, 2024.